Stockreport

A Look at Jazz Pharmaceuticals's Valuation After Breakthrough Phase 3 Ziihera Trial Results [Yahoo! Finance]

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
PDF Jazz Pharmaceuticals (JAZZ) announced its Phase 3 HERIZON-GEA-01 trial showed that Ziihera, combined with chemotherapy, delivered significant improvements in progression [Read more]